EMILY RUNYAN: Open Payments
NPI 1285894709 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 36 payments from 13 companies in 2025. Trend: 2023 $77 · 2024 $776 · 2025 $1,205
Food & beverage: $1,205
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $315 |
| AstraZeneca Pharmaceuticals LP | 11 | $171 |
| ABBVIE INC. | 4 | $144 |
| Axsome Therapeutics, Inc. | 2 | $142 |
| Teva Pharmaceuticals USA, Inc. | 3 | $138 |
| Otsuka America Pharmaceutical, Inc. | 2 | $91 |
| Novo Nordisk Inc | 4 | $82 |
| SANOFI PASTEUR INC. | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: INVEGA SUSTENNA, Auvelity, AUSTEDO XR, VRAYLAR, AIRSUPRA, BREZTRI, REXULTI, Rybelsus.
Industry payments across KS — which companies pay providers there.
